The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and clinical validity of tumor genomic testing for guiding active surveillance selection in men with NCCN intermediate-risk prostate cancer.
 
Lauren Lenz
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Wyatt Clegg
Employment - Myriad Genetics Genetic Laboratories, Inc.
Stock and Other Ownership Interests - Myriad Genetics Medical Laboratories, Inc.
 
Diana Iliev
No Relationships to Disclose
 
Howard Korman
Research Funding - Myriad Genetics
 
Todd Matthew Morgan
Consulting or Advisory Role - Foundation Medicine; Stratify Genomics; Tempus
Research Funding - MDxHealth (Inst)
 
Jason Hafron
Employment - Michigan Institute of Urology
Honoraria - Amgen; Astellas Pharma; Bayer; Blue Earth Diagnostics; Dendreon; Janssen Biotech; Lantheus Medical Imaging; Merck; Myovant Sciences; Myriad Genetics; Pfizer; Procept Biorobotics; Tolmar; Urogen pharma
Consulting or Advisory Role - Astellas Pharma; Dendreon; Janssen Biotech; Lilly; LynxDx; Myovant Sciences; Myriad Genetics; Pfizer; Promaxo
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Blue Earth Diagnostics; Dendreon; Janssen Biotech; Myovant Sciences; Myriad Genetics; Pfizer; Procept Biorobotics; Tolmar; Urogen pharma
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Janssen Biotech (Inst); Lipella Pharmaceuticals (Inst); Merck (Inst); miR Scientific (Inst); Myovant Sciences (Inst); Myriad Genetics (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Dendreon; Janssen Biotech; Merck; Myovant Sciences; Pfizer; Tolmar; Urogen pharma
 
Alexander DeHaan
No Relationships to Disclose
 
Ronald F. Tutrone
Employment - Chesapeake Urology
Stock and Other Ownership Interests - Compass Therapeutics; GlaxoSmithKline; Myovant Sciences; Novartis; Nymox; Veru
Consulting or Advisory Role - Exosome Diagnostics; Myovant Sciences; Novartis; Nymox
Speakers' Bureau - Exosome Diagnostics; Medivation/Astellas; Pfizer
Research Funding - Advantagene (Inst); Bayer (Inst); Dendreon (Inst); Exosome Diagnostics (Inst); Genomic Health (Inst); Janssen Oncology (Inst); MDxHealth (Inst); Medivation/Astellas (Inst); Merck (Inst); POINT Biopharma (Inst); Veru (Inst)
 
Timothy Richardson
No Relationships to Disclose
 
Kevin Cline
No Relationships to Disclose
 
Paul M. Yonover
No Relationships to Disclose
 
Jeff Jasper
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
Travel, Accommodations, Expenses - Myriad Genetics
 
Alexander Gutin
Employment - Myriad Genetics; Myriad Genetics (I)
Stock and Other Ownership Interests - Myriad Genetics; Myriad Genetics (I)
Consulting or Advisory Role - DermTech
 
Robert Finch
Employment - Myriad Genetic Laboratories
Stock and Other Ownership Interests - Myriad Genetic Laboratories
Travel, Accommodations, Expenses - Myriad Genetic Laboratories
 
Thomas Paul Slavin
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics; Oncodea
Consulting or Advisory Role - Myriad Genetics; Oncodea
 
Todd Cohen
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
Consulting or Advisory Role - Myriad Genetics